Position in VTRS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$8,300,555
+$2,444,092 QoQ
Shares Held
522,705
+20.6% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 123 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $87,470,140 across 16 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
205,871 | $34,697,498 | |
| 2 | ZTS |
Zoetis Inc.
|
228,467 | $16,417,638 | |
| 3 | VTRS |
Viatris Inc
This page
|
522,705 | $8,300,555 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
13,120 | $7,108,809 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
165,300 | $4,068,033 | |
| 6 | ALKS |
Alkermes plc.
|
55,000 | $2,881,725 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
23,600 | $2,618,184 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
60,000 | $2,080,200 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,300,555 | 522,705 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $5,856,463 | 433,491 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $4,925,755 | 395,643 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,347,190 | 338,100 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,766,514 | 309,800 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,698,358 | 309,800 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,857,010 | 309,800 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $10,702,852 | 921,865 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $9,527,552 | 896,289 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $8,858,130 | 741,887 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,335,988 | 1,046,721 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $13,233,717 | 1,342,162 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $13,394,776 | 1,342,162 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $15,184,544 | 1,578,435 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $16,309,712 | 1,465,383 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $6,044,709 | 709,473 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $7,428,182 | 709,473 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $3,221,829 | 296,124 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,312,660 | 318,748 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,261,434 | 314,497 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,494,162 | 314,497 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $4,143,599 | 296,607 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $5,492,169 | 293,072 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||